ATE128355T1 - Mischungen gegen husten/erkältungen mit gehalt an nichtsedierenden antihistaminika. - Google Patents

Mischungen gegen husten/erkältungen mit gehalt an nichtsedierenden antihistaminika.

Info

Publication number: ATE128355T1
Authority: AT; Austria
Prior art keywords: cough; sedating; cold; anthistaminics; mixtures containing
Prior art date: 1987-04-24

Application number

AT88904126T

Other languages

English (en)

Inventor

Abraham Sunshine

Eugene M Laska

Carole E Siegel

Original Assignee

Abraham Sunshine

Eugene M Laska

Carole E Siegel

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1987-04-24

Filing date

1988-04-22

Publication date

1995-10-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21920155&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE128355(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1988-04-22 Application filed by Abraham Sunshine, Eugene M Laska, Carole E Siegel filed Critical Abraham Sunshine

1995-10-15 Application granted granted Critical

1995-10-15 Publication of ATE128355T1 publication Critical patent/ATE128355T1/de

Links

206010011224 Cough Diseases 0.000 title abstract 2
239000000203 mixture Substances 0.000 title 1
229940124584 antitussives Drugs 0.000 abstract 2
206010019233 Headaches Diseases 0.000 abstract 1
208000002193 Pain Diseases 0.000 abstract 1
206010037660 Pyrexia Diseases 0.000 abstract 1
GUGOEEXESWIERI-UHFFFAOYSA-N Terfenadine Chemical compound C1=CC(C(C)(C)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 GUGOEEXESWIERI-UHFFFAOYSA-N 0.000 abstract 1
230000000954 anitussive effect Effects 0.000 abstract 1
230000001387 anti-histamine Effects 0.000 abstract 1
239000000739 antihistaminic agent Substances 0.000 abstract 1
239000003434 antitussive agent Substances 0.000 abstract 1
239000000850 decongestant Substances 0.000 abstract 1
ZZVUWRFHKOJYTH-UHFFFAOYSA-N diphenhydramine Chemical compound C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 ZZVUWRFHKOJYTH-UHFFFAOYSA-N 0.000 abstract 1
239000003172 expectorant agent Substances 0.000 abstract 1
230000003419 expectorant effect Effects 0.000 abstract 1
231100000869 headache Toxicity 0.000 abstract 1
206010022000 influenza Diseases 0.000 abstract 1
206010025482 malaise Diseases 0.000 abstract 1
239000000041 non-steroidal anti-inflammatory agent Substances 0.000 abstract 1
229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1
230000001624 sedative effect Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Emergency Medicine (AREA)
Organic Chemistry (AREA)
Pain & Pain Management (AREA)
General Chemical & Material Sciences (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Engineering & Computer Science (AREA)
Biomedical Technology (AREA)
Rheumatology (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

AT88904126T 1987-04-24 1988-04-22 Mischungen gegen husten/erkältungen mit gehalt an nichtsedierenden antihistaminika. ATE128355T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US07/042,120 US4783465A (en)	1984-04-09	1987-04-24	Cough/cold mixtures comprising non-sedating antihistamine drugs

Publications (1)

Publication Number	Publication Date
ATE128355T1 true ATE128355T1 (de)	1995-10-15

Family

ID=21920155

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT88904126T ATE128355T1 (de)	1987-04-24	1988-04-22	Mischungen gegen husten/erkältungen mit gehalt an nichtsedierenden antihistaminika.

Country Status (9)

Country	Link
US (1)	US4783465A (de)
EP (1)	EP0311677B1 (de)
JP (1)	JPH01503539A (de)
AT (1)	ATE128355T1 (de)
AU (1)	AU610178B2 (de)
CA (1)	CA1327315C (de)
DE (1)	DE3854518T2 (de)
WO (1)	WO1988008302A1 (de)
ZA (1)	ZA882884B (de)

Families Citing this family (61)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU643187B2 (en) *	1984-04-09	1993-11-11	Eugene M. Laska	Cough-cold mixtures comprising non-steroidal anti-inflammatory drugs
GB8707416D0 (en) *	1987-03-27	1987-04-29	Wellcome Found	Pharmaceutical formulations
GB8805268D0 (en) *	1988-03-04	1988-04-07	Glaxo Group Ltd	Medicaments
US4999226A (en) *	1988-06-01	1991-03-12	Merrell Dow Pharmaceuticals Inc.	Pharmaceutical compositions for piperidinoalkanol-ibuprofen combination
US4933172A (en) *	1988-10-06	1990-06-12	Warner-Lambert Co.	Method of and compositions for treating destructive periodontal disease
US4990535A (en) *	1989-05-03	1991-02-05	Schering Corporation	Pharmaceutical composition comprising loratadine, ibuprofen and pseudoephedrine
WO1992004022A1 (en) *	1990-09-11	1992-03-19	Richardson Vicks Inc.	Use of compositions containing 2-(6'-substituted-2'-naphthyl)-acetic acid derivatives for the treatment of respiratory disorders
WO1992005783A1 (en) *	1990-09-28	1992-04-16	Merck & Co., Inc.	Ibuprofen-antihistamine combinations
WO1992015332A1 (en) *	1991-03-04	1992-09-17	Warner-Lambert Company	Novel salts/ion pairs of non-steroidal anti-inflammatory drugs in various dosage forms
FR2673842B1 (fr) *	1991-03-13	1993-12-24	Rhone Poulenc Rorer Sa	Nouvelles compositions liquides a base de derives de la piperidine substitues en 1,4.
US5164398A (en) *	1991-04-01	1992-11-17	Merck & Co., Inc.	Ibuprofen-antitussive combinations
JPH06506684A (ja) *	1991-04-01	1994-07-28	メルク　エンド　カンパニー　インコーポレーテッド	イブプロフェン−充血除去剤配合物
FR2684298B1 (fr) *	1991-12-03	1994-03-11	Rhone Poulenc Rorer Sa	Nouvelles compositions pharmaceutiques solides a base de derives de lapiperidine substitues en 1,4.
US5451401A (en) *	1993-09-29	1995-09-19	The Procter & Gamble Company	Diphosphonic acid esters as tartar control agents
US5691352A (en) *	1993-10-25	1997-11-25	Merrell Pharmaceuticals Inc.	Stable pharmaceutical composition of terfenadine and ibuprofen
JP3779349B2 (ja) *	1995-04-24	2006-05-24	興和株式会社	ピペリジン誘導体
US5906747A (en) *	1995-11-13	1999-05-25	Biosepra Inc.	Separation of molecules from dilute solutions using composite chromatography media having high dynamic sorptive capacity at high flow rates
US5648358A (en) *	1996-03-05	1997-07-15	Mitra; Sekhar	Compositions and methods for treating respiratory disorders
US6348216B1 (en) *	1996-06-10	2002-02-19	Knoll Pharmaceutical Company	Ibuprofen and narcotic analgesic compositions
US6361794B1 (en)	1996-06-12	2002-03-26	Basf Corporation	Method of making ibuprofen and narcotic analgesic composition
US5712310A (en) *	1996-06-14	1998-01-27	Alpharma Uspd, Inc.	Suspension of substantially water-insoluble drugs and methods of their manufacture
US6160020A (en) *	1996-12-20	2000-12-12	Mcneill-Ppc, Inc.	Alkali metal and alkaline-earth metal salts of acetaminophen
US6060060A (en) *	1997-01-31	2000-05-09	Bmb Patent Holding Corporation	Analgesic compositions from sweet peppers and methods of use thereof
GB2324242A (en) *	1997-04-18	1998-10-21	Atindra Nath Chakrabarty	Medicaments for treating viral infections
ZA984336B (en) *	1997-05-21	1998-11-30	Warner Lambert Co	Non-sedating acrivastine product
CA2304005A1 (en) *	1997-09-19	1999-04-01	The Procter & Gamble Company	Compositions and methods for treating respiratory disorders
IN188720B (de) *	1997-11-06	2002-11-02	Panacea Biotec Ltd
US6384038B1 (en) *	1998-04-14	2002-05-07	Sepracor Inc.	Methods and compositions using cetirizine in combination with leukotriene inhibitors or decongestants
US6194431B1 (en) *	1998-04-14	2001-02-27	Paul D. Rubin	Methods and compositions using terfenadine metabolites in combination with leukotriene inhibitors
US6132758A (en)	1998-06-01	2000-10-17	Schering Corporation	Stabilized antihistamine syrup
US6086888A (en) *	1998-12-22	2000-07-11	Bmb Patent Holding Corporation	Analgesic compositions from sweet bell peppers and methods of use thereof
US6211246B1 (en)	1999-06-10	2001-04-03	Mcneil-Ppc, Inc.	Rapidly absorbed liquid compositions
US6100274A (en) *	1999-07-07	2000-08-08	Schering Corporation	8-chloro-6,11-dihydro-11- ](4-piperidylidine)-5H-benzo[5,6]cyclohepta[1,2-bpyridine oral compositions
US6114346A (en)	1999-10-22	2000-09-05	Schering Corporation	Treating sleep disorders using desloratadine
WO2001045676A2 (en)	1999-12-20	2001-06-28	Schering Corporation	Extended release oral dosage composition
WO2001045668A2 (en) *	1999-12-20	2001-06-28	Schering Corporation	Stable extended release oral dosage composition comprising pseudoephedrine and desloratadine
US7405223B2 (en)	2000-02-03	2008-07-29	Schering Corporation	Treating allergic and inflammatory conditions
PA8500101A1 (es) *	2000-03-30	2002-09-17	Schering Corp	Composiciones y métodos para tratar condiciones alérgicas e inflamatorias con tos
US20030216423A1 (en) *	2000-05-24	2003-11-20	Sergio Ulloa	Stable liquid and solid formulations
AU2001264806A1 (en) *	2000-05-25	2001-12-03	Schering Corporation	Stable liquid and solid formulations
US6440983B1 (en) *	2000-12-21	2002-08-27	Mary Theresa Frank-Kollman	Compositions and methods for relieving headache symptoms in aspirin-sensitive headache sufferers
IL159287A0 (en)	2001-06-28	2004-06-01	Ucb Farchim Sa	Tablet comprising cetirizine and pseudoephedrine
US6863901B2 (en)	2001-11-30	2005-03-08	Collegium Pharmaceutical, Inc.	Pharmaceutical composition for compressed annular tablet with molded triturate tablet for both intraoral and oral administration
US6827946B2 (en)	2001-12-05	2004-12-07	Collegium Pharmaceutical, Inc.	Compositions containing both sedative and non-sedative antihistamines
CZ292874B6 (cs) *	2002-01-30	2003-12-17	Léčiva, A. S.	Farmaceutický prostředek k ošetření akutních bolestí
JP4614638B2 (ja) *	2002-06-07	2011-01-19	第一三共株式会社	鎮痛剤組成物
JP4614640B2 (ja) *	2002-07-04	2011-01-19	第一三共株式会社	解熱剤組成物
JP2010159299A (ja) *	2002-07-04	2010-07-22	Daiichi Sankyo Co Ltd	ロキソプロフェンとケトチフェンを含有する解熱剤組成物
US20040253311A1 (en) *	2002-12-18	2004-12-16	Roger Berlin	Multi-layer tablet comprising non-steroidal anti-inflammatory drugs, decongestants and non-sedating antihist amines
TWI313598B (en) *	2002-12-18	2009-08-21	Wyeth Corp	Compositions of non-steroidal anti-inflammatory drugs, decongestants and anti-histamines
GB0312419D0 (en) *	2003-05-30	2003-07-02	Boots Healthcare Int Ltd	Use of a compound in the treatment of sleep disorders and the like, in providing refreshedness on waking and a method for the treatment of grogginess
WO2008105920A1 (en) *	2007-02-28	2008-09-04	Collegium Pharmaceutical, Inc.	Antihistamine combination
EP3090739A1 (de) *	2008-01-04	2016-11-09	Schabar Research Associates LLC	Zusammensetzungen aus naproxen-natriumsalz und nizatidin
US8518439B2 (en) *	2008-12-03	2013-08-27	Novartis Ag	Liquid therapeutic composition
US10046052B2 (en) *	2010-05-14	2018-08-14	Bernard Silverman	Method and formulation for cold treatment in adults and children with increased safety
EP2985036A3 (de)	2014-08-14	2016-03-09	Fraunhofer Gesellschaft zur Förderung der angewandten Forschung e.V.	CYP2J2-Antagonisten zur Behandlung von Schmerzen
US11219629B2 (en)	2019-10-17	2022-01-11	Hooman M. MELAMED	Anesthetic pharmaceutical composition, system and method
CA3124579A1 (en)	2020-07-15	2022-01-15	Schabar Research Associates Llc	Unit oral dose compositions composed of naproxen sodium and famotidine for the treatment of acute pain and the reduction of the severity of heartburn and/or the risk of heartburn
IL299845A (en)	2020-07-15	2023-03-01	Schabar Res Associates Llc	Unit oral dose compositions composed of ibuprofen and famotidine for the treatment of acute pain and the reduction of the severity and/or risk of heartburn
US12514846B2 (en)	2020-07-15	2026-01-06	Schabar Research Associates Llc	Unit oral dose compositions composed of ibuprofen or a pharmaceutically acceptable salt thereof and famotidine or a pharmaceutically acceptable salt thereof for the treatment of acute pain and the reduction of the severity and/or risk of heartburn and/or upset stomach
MX2022015332A (es)	2020-12-04	2023-01-11	Laboratorios Silanes S A De C V	Composicion farmaceutica de un analgesico y un antihistaminico para el tratamiento de enfermedades respiratorias.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4522826A (en) *	1984-02-08	1985-06-11	Richardson-Vicks Inc.	Analgesic and anti-inflammatory compositions comprising diphenhydramine and methods of using same
US4552899A (en) *	1984-04-09	1985-11-12	Analgesic Associates	Cough/cold mixtures comprising non-steroidal anti-inflammatory drugs
US4810502A (en) *	1987-02-27	1989-03-07	Alza Corporation	Pseudoephedrine brompheniramine therapy

1987
- 1987-04-24 US US07/042,120 patent/US4783465A/en not_active Expired - Lifetime
1988
- 1988-04-22 EP EP88904126A patent/EP0311677B1/de not_active Revoked
- 1988-04-22 JP JP63503899A patent/JPH01503539A/ja active Pending
- 1988-04-22 ZA ZA882884A patent/ZA882884B/xx unknown
- 1988-04-22 WO PCT/US1988/001264 patent/WO1988008302A1/en not_active Ceased
- 1988-04-22 AU AU16873/88A patent/AU610178B2/en not_active Expired
- 1988-04-22 DE DE3854518T patent/DE3854518T2/de not_active Revoked
- 1988-04-22 CA CA000564793A patent/CA1327315C/en not_active Expired - Lifetime
- 1988-04-22 AT AT88904126T patent/ATE128355T1/de not_active IP Right Cessation

Also Published As

Publication number	Publication date
CA1327315C (en)	1994-03-01
DE3854518D1 (de)	1995-11-02
AU610178B2 (en)	1991-05-16
US4783465A (en)	1988-11-08
WO1988008302A1 (en)	1988-11-03
ZA882884B (en)	1988-10-27
EP0311677A1 (de)	1989-04-19
JPH01503539A (ja)	1989-11-30
DE3854518T2 (de)	1996-02-22
AU1687388A (en)	1988-12-02
EP0311677B1 (de)	1995-09-27

Legal Events

Date	Code	Title	Description
1996-05-15	UEP	Publication of translation of european patent specification
2000-12-15	RZN	Patent revoked

Publication	Publication Date	Title
ATE128355T1 (de)	1995-10-15	Mischungen gegen husten/erkältungen mit gehalt an nichtsedierenden antihistaminika.
US4552899B1 (de)	1992-10-20
AU1948488A (en)	1989-01-04	Cough/cold mixtures comprising non-sedating antihistamine drugs
MX9203278A (es)	1992-07-01	Pastilla de liberacion sustentada que comprende loratadina, ibuprofen y pseudoefedrina.
DK372786A (da)	1987-10-16	Farmaceutiske praeparater af phenindamin (2,3,4,9-tetrahydro-2-methyl-9-phenyl-1h-indeno(2,1-c)pyridin)
NO308771B1 (no)	2000-10-30	Filmbelagt, oralt doseringspreparat med forlenget frigivelse
MX9405219A (es)	1995-01-31	Nueva formulacion farmaceutica.
MX9600857A (es)	1997-06-28	Forma de dosificacion i en tabletas, con unidades multiples.
MX9706769A (es)	1997-11-29	Formas de dosificacion farmaceutica que comprenden un inhibidor de la bomba de protones y un agente procinetico.
TR199500832A2 (tr)	1996-06-21	Benzimidazol türevleri ve bunlarin medikal terapide kullanimi ve bunlari iceren farmasötik formülasyonlar.
IT1208735B (it)	1989-07-10	Formulazioni farmaceutiche a basedi arecolina e simili,lore preparazione ed impiego nel trattamento di disturbi della memoria
DK258989D0 (da)	1989-05-26	Anvendelse af et xanthinderivat til inhibering af tnf og middel hertil
AR008293A1 (es)	1999-12-29	Composicion que comprende una cantidad antihistaminica para el tratamiento de las respuestas alergicas de las vias respiratorias superiores
AR012376A1 (es)	2000-10-18	Formulacion de gel para la aplicacion topica
CO5031291A1 (es)	2001-04-27	Composicion farmaceutica
NO983926L (no)	1999-03-01	Farmas°ytisk kombinasjonspreparat av en inhibitor av natrium-hydrogen-veksler og et legemiddel for behandling av hjertekretsl°p-sykdommer
NO308527B1 (no)	2000-09-25	Substituerte 2-naftoylguanidiner, deres anvendelse for fremstilling av et medikament samt legemidler og preparater inneholdende forbindelsene
DE69026295D1 (de)	1996-05-09	Pharmazeutische Zusammensetzung gegen durch Vasokonstriktion hervorgerufene Krankheiten
DE3871159D1 (de)	1992-06-25	Pharmazeutische und tieraerztliche zusammensetzungen.
ITMI921573A0 (it)	1992-06-26	Dispositivo di somministrazione di farmaci particolarmente per aerosolterapia e simili
SE8702227D0 (sv)	1987-05-27	New use
IT8520654A0 (it)	1985-05-10	Derivato della piridina ad azione terapeutica, in particolare antiflogistica, analgesica e antipiretica; procedimento per prepararlo, uso farmaceutico e composizioni farmaceutiche che lo contengono.
ATE76295T1 (de)	1992-06-15	Pharmazeutische und tieraerztliche zusammensetzungen.
ES288168Y (es)	1986-08-01	Conjunto de impresos para el control en la prescripcion,dis-tribucion, y administracion de medicamentos en centros hos- pitalarios y similares
ATE78684T1 (de)	1992-08-15	Pharmazeutische loesung enthaltend salbutamol und cromoglycinsaeure.